Emel ATAYIK, Gökhan AYTEKİN
Journal of Health Sciences and Medicine
2022-Cilt: 5 - Sayı: 2
698-701
omalizumab, mepolizumab, SARS-CoV-2, omalizumab, mepolizumab, SARS-CoV-2
97 104